임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

13건 표시

2상모집 중· Diabetes Mellitus, Type 2
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
리드: 노보노디스크
상세 →NCT07668388
2상모집 중· Obesity
A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity
리드: 노보노디스크
상세 →NCT07639021
2상모집 중· Diabetes Mellitus, Type 2
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
리드: 노보노디스크
상세 →NCT07415954
2상모집 중· Overweight
A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
리드: 노보노디스크
상세 →NCT07395687
2상모집 중· Heart Failure
A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy
리드: 노보노디스크
상세 →NCT06979375
2상모집 중· Heart Failure
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
리드: 노보노디스크
상세 →NCT06979362
2상모집 중· Chronic Kidney Disease
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
리드: 노보노디스크
상세 →NCT06717698
2상모집 중· Diabetes type1
Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment
협력: 노보노디스크
상세 →NCT06411210
2상모집 중· NAFLD
Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
협력: 노보노디스크
상세 →NCT05424003
2상모집 중· Sickle Cell Disease
A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke
협력: 노보노디스크
상세 →NCT05953584
2상모집 중· Sickle Cell Disease
A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease
협력: 노보노디스크
상세 →NCT06198712
2상모집 중· Primary Hyperoxaluria Type 1
Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
리드: 노보노디스크
상세 →NCT04580420
2상모집 중· TBI (Traumatic Brain Injury)
Growth Hormone Replacement Therapy for Retried Professional Football Players
협력: 노보노디스크
상세 →NCT04121780

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.